Case Report: Diabetes Flatbush - From Ketoacidosis to Non Pharmacological Treatment;Relato de caso: Diabetes Flatbush - Da cetoacidose ao tratamento não-farmacológico

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 1, 2007, Pages 131-135

  Rodacki, Melanie ^a,b   Zajdenverg, Lenita ^a   Lima, Giovana Aparecida B ^a   Nunes, Reinaldo Cavalcante ^a   Milech, Adolpho ^a   De Oliveira, José Egídio Paulo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Diabetes mellitus; Diabetic ketoacidosis; Diagnosis

Indexed keywords

ANTIDIABETIC AGENT; AUTOANTIBODY; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CASE REPORT; CAUCASIAN; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET THERAPY; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PREGNANCY DIABETES MELLITUS;

ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HLA-DR ANTIGENS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 34247171808     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302007000100021     Document Type: Article

References (15)

1. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity-onset diabetes of youth in black Americans. N Engl J Med 1987;316(6):285-91.
2. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994;43(6):741-5.
3. Linfoot P, Bergstrom C, Ipp E. Pathophysiology of ketoacidosis in type 2 diabetes mellitus. Diabetes Med 2005; 22(10):1414-9.
4. Sobngwi E, Gautier J-F. Adult-onset idiophatic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 2002;45:283-5.
5. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Int Med 1999;159(19):2317-22.
6. Pitteloud N, Philippe J. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 2000;130(16):576-82.
7. Kitabchi AE. Ketosis-prone diabetes - a new subgroup of patients with atypical type 1 and type 2 diabetes? J Clin Endocrinol Metab 2003;88(11):5087-9.
8. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003;88(11):5090-8.
9. Westphal SA. The occurrence of diabetic ketoacidosis in noninsulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 1996;101(1):19-24.
10. Maldonado MR, Otiniano ME, Cheema F, Rodriguez L, Balasubramanyam A. Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved β-cell function. Diabet Med 2005;22(12):1744- 50.
11. Hsin Yu E, Guo HR, Wu TJ. Factors associated with discontinuing insulin therapy after ketoacidosis in adult diabetic patients. Diabet Med 2003;20(4):333.
12. Umpierrez GE, Woo W, Hagopian WA. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with Diabetic Ketoacidosis. Diabetes Care 1999;22:1517-23.
13. Banerji MA, Chaiken RL, Lebovitz HE. Prolongation of near normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes 1995; 44: 466-70.
14. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004; 53(3): 645-53.
15. Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004;13(24):3151-9.